Official Journal of Research Center for Gastroenterology and Liver Diseases
OpenCitations
Works that cite this article, indexed by OpenCitations.
The Rising Threat of Hepatocellular Carcinoma in the Middle East and North Africa Region: Results From Global Burden of Disease Study 2017
Clinical Liver Disease 14(6) (2019)
Heidar Sharafi; Seyed Moayed Alavian
Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders
Virology Journal 18(1) (2021)
Heidar Sharafi; Bita Behnava; Alireza Azizi-saraji; Ali Namvar; Ali Anvar; Shima Salimi; Seyed Moayed Alavian
Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
BMJ Open 12(6) (2022)
Mohammad Tasavon Gholamhoseini; Heidar Sharafi; Helena HL Borba; Seyed Moayed Alavian; Asma Sabermahani; Behzad Hajarizadeh
Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis
Bulletin of the World Health Organization 98(3) (2019)
Hugo Perazzo; Rodolfo Castro; Paula M Luz; Mariana Banholi; Rafaela V Goldenzon; Sandra W Cardoso; Beatriz Grinsztejn; Valdilea G Veloso
Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review
Hepatitis Monthly In Press(In Press) (2018)
Saman Mohazzab-Torabi; Fardin Dolatimehr; Heidar Sharafi; Mahdi Safi-Abadi; Mohammad Saeid Rezaee-Zavareh; Ehsan Bayatpour; Hamidreza Karimi-Sari; Seyed Moayed Alavian
Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017
Hepatitis Monthly 17(11) (2017)
Seyed Moayed Alavian; Heidar Sharafi
Prevalence of hepatitis C virus NS5A resistance-associated substitutions in chronic infection with genotype 1: A pooled analysis based on deposited sequences in GenBank
Virus Research 259 (2019)
Heidar Sharafi; Saeideh Maleki; Seyed Moayed Alavian
Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country
Journal of Clinical Virology Plus 4(3) (2024)
Marcarious M. Tantuoyir; Muhammed Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad
Seroprevalence of Hepatitis C Virus among Blood Donors in Middle Eastern Countries: A Systematic Review and Meta-Analysis
Iranian Red Crescent Medical Journal 19(12) (2017)
Hossein Ghaderi-Zefrehi; Heidar Sharafi; Farzin Sadeghi; Mohammad Gholami-Fesharaki; Alireza Farasat; Fatemeh Jahanpeyma; Seyed Moayed Alavian
Comment on ‘Efficacy of daclatasvir-based quadruple therapy in nonresponder patients infected by hepatitis C virus genotype 4: the ANRS HC32 QUATTRO study’
European Journal of Gastroenterology & Hepatology 30(7) (2018)
Seyed M. Alavian; Heidar Sharafi
Hepatitis C resistance to NS5A inhibitors: Is it going to be a problem?
World Journal of Hepatology 10(9) (2018)
Heidar Sharafi; Seyed Moayed Alavian
Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting
Journal of Clinical Virology 113 (2019)
Heidar Sharafi; Hossein Poustchi; Fatemeh Azimian; Babak Tamadoni; Rashid Ramezani; Mohamad Mehdi Gouya; Mahdi Sheikh; Farnaz Hashemi; Mehrzad Tashakorian; Ramin Alasvand; Seyed Moayed Alavian; Shahin Merat
Pooled Prevalence of NS5A Resistance-Associated Substitutions in Chronic HCV Genotype 3 Infection: A Study Based on Deposited Sequences in GenBank
Microbial Drug Resistance 25(7) (2019)
Heidar Sharafi; Saman Ghalamkari; Alireza Hassanshahi; Seyed Moayed Alavian